Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Feb 15, 2022 8:20pm

635 Views

Post# 34432160

RE:RE:BTD

The time line of 2022 for BTD is currently based off data backlocking from NOV 29 2021.
And that latest corprate prezzy is based off that data.

Shall the market expect new data may affect the timetable?

Well yes, it already has.. Look at the timetable in the corp prezzy the quarter back.

Yep that copr prezzy date is moving closer to us with the new data releases.
And of course that data is only up till nov 29 2021.

We will get some data updaates in 2022 also.

Yep prolly more data and no quarterly newsletters anymore.
Hell i dont' know im just a hick doin oil changes... LOL

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec